MiniMed (MMED) Revenue (2025 - 2026)
MiniMed (MMED) posted Revenue of $843.0 million for Q3 2026, up 0.72% quarter-over-quarter from $837.0 million in Q2 2026, and up 16.6% YoY from $723.0 million in Q3 2025.
Powered by 
Analysis
MiniMed (MMED) Revenue (2025 - 2026) Analysis & Trends
MiniMed (MMED) has 2 years of Revenue data on file, last reported at $843.0 million in Q3 2026.
- For the quarter ending Q3 2026, Revenue rose 16.6% year-over-year to $843.0 million; the trailing twelve-month figure through Jul 2026 stood at $3.2 billion (changed N/A YoY), and the FY2026 full-year result was $3.1 billion, up 14.25% from the prior year.
- Revenue was $843.0 million for Q3 2026 at MiniMed, up from $837.0 million in the prior quarter.
- In the past five years, Revenue ranged from a high of $843.0 million in Q3 2026 to a low of $687.0 million in Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 177.43 Bn | 172.48 Bn | 7.27 Bn | 12.59 Bn |
| 2 | Intuitive Surgical | 139.20 Bn | 134.11 Bn | 1.96 Bn | 2.89 Bn |
| 3 | Medtronic | 118.01 Bn | 109.81 Bn | 6.34 Bn | 9.76 Bn |
| 4 | Stryker | 105.44 Bn | 101.96 Bn | 4.50 Bn | 6.59 Bn |
| 5 | Boston Scientific | 62.90 Bn | 62.60 Bn | 3.85 Bn | 5.44 Bn |
| 6 | Edwards Lifesciences | 50.87 Bn | 46.72 Bn | 1.35 Bn | 1.74 Bn |
| 7 | Dexcom | 33.72 Bn | 31.77 Bn | 830.00 Mn | 1.31 Bn |
| 8 | Resmed | 32.45 Bn | 30.98 Bn | 861.22 Mn | 1.46 Bn |
| 9 | Alcon | 31.70 Bn | 30.25 Bn | 1.68 Bn | 2.78 Bn |
| 10 | MiniMed | 6.13 Bn | 5.92 Bn | 465.00 Mn | 843.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 843.00 Mn |
| Apr 24, 2026 | 837.00 Mn |
| Jan 23, 2026 | 790.00 Mn |
| Apr 25, 2025 | 724.00 Mn |
| Jan 24, 2025 | 687.00 Mn |